Washington-Watch
FDA General
More in FDA General
38% of patients treated with IL-13 blocker achieved clear or almost-clear skin at 16 weeks
Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis
Designed for certain models, software can customize audio parameters
Clinicians should perform liver blood tests before and during Veozah treatment
In trials, guselkumab more than doubled remission rates versus placebo
Agency advisory panel to examine complicated efficacy data and liver safety concerns
Lawmakers also queried officials about a menthol cigarette rule and labeling of milk alternatives
Concerns about patient selection, antibiotic resistance dominated the discussion
New food ingredients are a "complete black box," one expert says
Oral antibiotic has potential for inappropriate use, agency says
Health news and commentary gathered by 鶹ý staff
Rate fell to under 6% this year, down from 7.7% in 2023
AP finds inspections are lacking nationally and abroad
